Education
About Us
Working with TipRanks
Follow Us
Semler Scientific (SMLR)
NASDAQ:SMLR
SMLR Stock Chart & Stats
$20.67
-$4.62(-8.36%)
At close: 4:00 PM EST
$20.67
-$4.62(-8.36%)
Day’s Range― - ―
52-Week Range$14.89 - $66.50
Previous CloseN/A
Volume122.03K
Average Volume (3M)407.87K
Market Cap
$316.10M
Enterprise Value$505.77M
Total Cash (Recent Filing)$10.18M
Total Debt (Recent Filing)$116.42M
Price to Earnings (P/E)7.4
Beta1.84
Next Earnings
Mar 10, 2026EPS Estimate
-0.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.32
Shares Outstanding15,285,092
10 Day Avg. Volume402,755
30 Day Avg. Volume407,865
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)1.69
Price to Sales (P/S)6.93
P/FCF Ratio16.03
Enterprise Value/Market Cap1.60
Enterprise Value/Revenue13.69
Enterprise Value/Gross Profit15.08
Enterprise Value/Ebitda-10.84
Forecast
1Y Price Target
$51.00Price Target Upside146.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Acquisition And Strategic MonetizationThe all-stock acquisition by Strive and plans to explore monetizing or distributing Semler’s diagnostics business could unlock shareholder value and create strategic opportunities under new management.
Product AdoptionQuantaFlo, a rapid point-of-care test for peripheral artery disease, could become the standard-of-care and drive broader clinical adoption and revenue growth.
Regulatory ApprovalAnticipated 510(k) clearance for a device using QuantaFlo technology to detect heart failure and arrhythmia could materially expand the addressable market and support a return to growth.
Bears Say
Breakup Fee ObligationIf the acquisition is not completed, Semler may be obligated to pay a $49 million breakup fee payable in cash or Bitcoin, posing a significant financial liability.
Customer ConcentrationA significant customer reducing its usage of QuantaFlo creates material revenue headwinds and highlights dependence on a small number of large customers.
Reimbursement And Revenue PressureNew Medicare Advantage risk adjustment models and lower reimbursement rates for PAD screening are expected to reduce revenue and pressure margins.
Semler Scientific News
SMLR FAQ
What was Semler Scientific’s price range in the past 12 months?
Semler Scientific lowest stock price was $14.88 and its highest was $66.50 in the past 12 months.
What is Semler Scientific’s market cap?
Semler Scientific’s market cap is $316.10M.
When is Semler Scientific’s upcoming earnings report date?
Semler Scientific’s upcoming earnings report date is Mar 10, 2026 which is in 60 days.
How were Semler Scientific’s earnings last quarter?
Semler Scientific released its earnings results on Nov 12, 2025. The company reported -$0.32 earnings per share for the quarter, missing the consensus estimate of -$0.145 by -$0.175.
Is Semler Scientific overvalued?
According to Wall Street analysts Semler Scientific’s price is currently Undervalued.
Does Semler Scientific pay dividends?
Semler Scientific does not currently pay dividends.
What is Semler Scientific’s EPS estimate?
Semler Scientific’s EPS estimate is -0.54.
How many shares outstanding does Semler Scientific have?
Semler Scientific has 15,285,092 shares outstanding.
What happened to Semler Scientific’s price movement after its last earnings report?
Semler Scientific reported an EPS of -$0.32 in its last earnings report, missing expectations of -$0.145. Following the earnings report the stock price went down -5.923%.
Which hedge fund is a major shareholder of Semler Scientific?
Currently, no hedge funds are holding shares in SMLR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Semler Scientific Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$51.00 (146.73% Upside)
$51.00 (146.73% Upside)
Blogger Sentiment
Bullish
SMLR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 377.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-62.56%
12-Months-Change
Fundamentals
Return on Equity
17.74%
Trailing 12-Months
Asset Growth
547.20%
Trailing 12-Months
Company Description
Semler Scientific
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
SMLR Stock 12 Month Forecast
Average Price Target
$51.00
▲(146.73% Upside)
Technical Analysis
Ownership Overview
12.14% Insiders
10.80% Mutual Funds
20.93% Other Institutional Investors
45.35% Public Companies and
Individual Investors